CD8A and neoplasm: In the MB49 tumor model, flow cytometry analysis revealed a higher proportion of FLT3+ phenotype CD8+ T cells in tumor-derived CD8+ T cells compared to spleen-derived CD8+ T cells (Figure 4A).